Less Ads, More Data, More Tools Register for FREE

Pin to quick picksELTA.L Regulatory News (ELTA)

  • There is currently no data for ELTA

Pathfinder Publication

22 Jul 2009 17:36

RNS Number : 1272W
Electra Private Equity PLC
22 July 2009
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO AUSTRALIA CANADA JAPAN OR THE UNITED STATES OF AMERICA OR TO US PERSONS

THIS ANNOUNCEMENT IS AN ADVERTISMENT AND NOT A PROSPECTUS AND INVESTORS SHOULD NOT SUBSCRIBE FOR OR PURCHASE ANY SHARES REFERRED TO IN THIS ANNOUNCEMENT EXCEPT ON THE BASIS OF INFORMATION IN THE PROSPECTUS to be PUBLISHED BY ELECTRA PRIVATE EQUITY INVESTMENTS PLC IN CONNECTION WITH THE PROPOSED PLACING

22nd July 2009

ELECTRA PRIVATE EQUITY PLC

PATHFINDER PUBLICATION

Electra Private Equity plc ("Electra") announces that its new wholly-owned subsidiary, Electra Private Equity Investments PLC (the "Company") has today published its pathfinder prospectus (the "Pathfinder") in connection with the institutional cash placing (a "Placing") to raise gross proceeds of up to £60 million by the issue of 7 year term Zero Dividend Preference Shares ("ZDP Shares") as announced on 20th July 2009

The Placing and the Pathfinder are only being directed at and made available to certain limited institutional investors. Neither the Pathfinder nor the Placing are being made available to the public.

For further information, please contact:

J.P. Morgan Cazenove Limited

Michael Wentworth-Stanley/William Simmonds Tel: + 44 (0)20 7588 2828

For Electra Private Equity PLC and Electra Partners LLP

Louise Hatch, M:Communications Tel: + 44 (0)20 7153 1516

Caroline Villiers, M:Communications Tel: + 44 (0)20 7153 1521

PROSPECTUS

Copies of the prospectus can be obtained, once available, subject to all applicable law, at no cost from the registered office of the Company, at Paternoster House, 65 St Paul's Churchyard, London EC4M 8AB, and the registered office of Clifford Chance LLP, at 10 Upper Bank Street, London E14 5JJ.

IMPORTANT INFORMATION

J.P. Morgan Cazenove Limited, which is authorised and regulated by the Financial Services Authority, is acting for the Company and Electra and no-one else in connection with the Placing and will not regard any other person as its client in relation to the Placing and will not be responsible to anyone other than the Company and Electra for providing the protections afforded to its clients, or for providing advice in relation to the Placing, the contents of this announcement or any other matter referred to herein.

This announcement and the Pathfinder are for information purposes only and do not constitute an invitation to subscribe for or otherwise acquire or dispose of any securities of the Company or Electra in any jurisdiction. The information contained in this announcement is for background purposes only and does not purport to be full or complete. No reliance may be placed for any purpose on the information contained in this announcement or the Pathfinder or their accuracy or completeness. This announcement and the Pathfinder do not constitute or form part of any offer to issue or sell, or any solicitation of any offer to subscribe or purchase, any investments nor shall it (or the fact of its distribution) form the basis of, or be relied on in connection with, any contract therefor.

Acquiring investments to which this announcement relates may expose an investor to a risk of losing all of the amount invested. Persons considering investing in such investments should consult an authorised person specialising in advising on such investments. This announcement does not constitute a recommendation concerning the Placing. The value of shares (including zero dividend preference shares) can go down as well as up. Past performance is not a guide to future performance. Potential investors should consult a professional advisor as to the suitability of the Placing for the person concerned.

The Pathfinder is being distributed only to and is directed only at: (a) persons who have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "Order"); or (b) other persons to whom it may otherwise lawfully be communicated (all such persons together referred to as "relevant persons"). Any person who is not a relevant person should not act or rely on the Pathfinder or any of its contents. Any investment or investment activity to which the Pathfinder relates is available only to relevant persons and will be engaged in only with relevant persons. 

Allocations in the Placing will only be made available to institutional investors in the UK and elsewhere outside the US in reliance on Regulation S under the US Securities Act of 1933.

This announcement, the Pathfinder (or any part of it) and the information contained herein and therein are not for publication, distribution, reproduction or release in or into, directly or indirectly, the United States of America. These materials do not contain or constitute an offer of securities for sale in the United States. The securities referred to herein have not been and will not be registered under the US Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration under that Act or an available exemption from it. The Company does not intend to register the securities or conduct a public offering in the United States. Neither the Company nor Electra will be registered under the US Investment Company Act of 1940, as amended, and investors will not be entitled to the benefits of that Act.

No securities issued or to be issued by the Company or Electra have been or will be registered under the applicable securities laws of Australia, Canada or Japan and, subject to certain exceptions, such securities may not be offered or sold in Australia, Canada or Japan.

The Placing and the distribution of this announcement and the Pathfinder in certain jurisdictions may be restricted by law and persons into whose possession any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOECKBKNABKDPOB
Date   Source Headline
15th Sep 201712:12 pmRNSDirector Declaration
31st Jul 201712:05 pmRNSDirector Declaration
24th Jul 20174:48 pmRNSHolding(s) in Company
18th Jul 20171:54 pmRNSHolding(s) in Company
17th Jul 20177:00 amRNSDirector/PDMR Shareholding
12th Jul 20179:14 amRNSDirector Declaration
27th Jun 20179:39 amRNSHalf-year Report
19th Jun 201710:15 amRNSDirector/PDMR Shareholding
14th Jun 20173:22 pmRNSDirector/PDMR Shareholding
14th Jun 20173:22 pmRNSDirector/PDMR Shareholding
13th Jun 20175:25 pmRNSDirector/PDMR Shareholding
8th Jun 20173:46 pmRNSDirector/PDMR Shareholding
1st Jun 20177:00 amRNSCompany Update
25th May 20177:00 amRNSHalf-year Report
24th May 201711:04 amRNSEpiris announces the sale of PINE Unit Trust
15th May 20177:00 amRNSEpiris announces the sale of TechInsights
24th Apr 201712:28 pmRNSChange of Registered Office
21st Apr 20177:00 amRNSEpiris receives £67 million from the sale of RISI
19th Apr 20177:00 amRNSEpiris Sells CALA & Retirement Bridge Investments
7th Apr 20177:42 amRNSEpiris sells remaining stake in Hollywood Bowl
7th Apr 20177:00 amRNSEpiris completes the sale of Treetops Nurseries
31st Mar 20177:00 amRNSEpiris completes the sale of Audiotonix
30th Mar 20179:40 amRNSHolding(s) in Company
30th Mar 20177:00 amRNSEpiris agrees the sale of Treetops Nurseries
24th Mar 20177:00 amRNSSpecial Dividend
23rd Mar 20174:39 pmRNSDirectorate Change
23rd Mar 20174:34 pmRNSResolutions passed at AGM - 23 March 2017
23rd Mar 20171:12 pmRNSResult of AGM
23rd Mar 20177:00 amRNSEpiris announces the realisation of Allflex
17th Mar 20174:35 pmRNSPrice Monitoring Extension
6th Mar 20177:00 amRNSEpiris completes sale of interest in Innovia Group
6th Mar 20177:00 amRNSEpiris completes £1.35b sale of Parkdean Resorts
3rd Mar 20177:06 amRNSEpiris announces the sale of RISI for $125 million
16th Feb 20177:04 amRNSEpiris announces the sale of OAG
3rd Feb 20177:00 amRNSEpiris announces the sale of Audiotonix
30th Jan 20174:25 pmRNSNotice of AGM
30th Jan 20174:25 pmRNSAnnual Financial Report
30th Jan 201710:00 amRNSEpiris sells Davies Group for £90 million
3rd Jan 201710:56 amRNSTotal Voting Rights
28th Dec 20162:27 pmRNSHolding(s) in Company
23rd Dec 20163:29 pmRNSNotification of cancelled shares, Voting Rights
23rd Dec 20163:16 pmRNSHolding(s) in Company
22nd Dec 20165:27 pmRNSDirector/PDMR Shareholding
22nd Dec 20167:00 amRNSResults of Tender Offer
20th Dec 20167:00 amRNSSale of Electra's interest in Innovia announced
19th Dec 20167:00 amRNSEpiris agrees £1.35b sale of Parkdean Resorts
14th Dec 20164:58 pmRNSHolding(s) in Company
9th Dec 20167:00 amRNSPreliminary Announcement for the Full Year
2nd Dec 20162:55 pmRNSResult of Meeting
18th Nov 20167:00 amRNSBoard Appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.